Skip to main content

Test Price

1,100 AED

✅ Home Collection Available

MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes) Mutation Detection Test in UAE | 1100 AED | DHA Licensed

Executive Summary & Core Metrics

This test delivers 99.9% diagnostic sensitivity for the m.3243A>G mutation via ISO 9001:2015 accredited molecular genetics laboratory, with VIP mobile phlebotomy and temperature-controlled cold-chain home collection (available daily from 8 AM to 11 PM). Includes telephonic post-test clinical guidance and direct insurance billing verification via WhatsApp. The service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent follows Federal Decree-Law No. 4 of 2016 on Medical Liability.

Test Overview & Methodology

The MELAS mutation detection test analyzes the mitochondrial genome for the pathogenic m.3243A>G variant in the MTTL1 gene, the most common cause of this multisystemic disorder. Offered at 1100 AED with a 5-day turnaround, it surpasses broader panels by delivering targeted, rapid, and cost-effective molecular confirmation essential for clinical management. The methodology employs PCR amplification followed by Sanger sequencing, providing analytical sensitivity exceeding 99% for the targeted variant.

Parameter Our Test Whole Mitochondrial Genome Sequencing
Methodology PCR + Sanger Sequencing Next-Generation Sequencing (NGS)
Analytical Sensitivity >99% for m.3243A>G ~98% for point mutations; higher chance of variants of uncertain significance
Turnaround Time 5 days (Mon–Fri) 14–21 days
Price 1100 AED 2800–3500 AED

Physician Insight & Safety Protocols

“A positive MELAS mutation result provides a concrete molecular anchor for diagnosis, yet it must be interpreted alongside clinical features such as short stature, seizures, and lactic acidemia. I strongly recommend discussing results with a neurologist or clinical geneticist experienced in mitochondrial disorders. Critically, patients should not discontinue any prescribed medications—especially anticonvulsants or metabolic supplements—without explicit physician guidance.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Advisory: Medication Safety & Clinical Monitoring

Do Not Stop Prescribed Therapy

Patients undergoing this genetic test must continue all prescribed treatments, including antiepileptic drugs, coenzyme Q10, L-carnitine, and other metabolic supplements. Any adjustment should only occur after consultation with the treating physician. Abrupt cessation can precipitate metabolic crises or stroke-like episodes.

Exclusion Criteria & Emergency Red Flags

  • Acute metabolic crisis with severe lactic acidosis (pH <7.1) — stabilize first before testing.
  • Asymptomatic minors without informed consent from a clinical geneticist and legal guardian, in accordance with UAE regulations.
  • Patients on anticoagulants with INR >3.0 — defer collection until INR is within therapeutic range.
  • If you experience sudden worsening of weakness, stroke-like episodes, or seizures, seek emergency medical attention immediately; this test does not replace urgent neurological care.

Patient FAQ & Clinical Guidance

1. What is the MELAS mutation detection test?

The MELAS mutation detection test identifies the m.3243A>G pathogenic variant in the MTTL1 gene through PCR and Sanger sequencing, providing a definitive molecular diagnosis in suspected mitochondrial encephalomyopathy cases. The test is performed on a peripheral blood sample collected under strict cold-chain conditions.

2. How is the test performed in the UAE?

A certified phlebotomist collects a 4 mL whole blood sample in an EDTA tube at your home (available daily 8 AM to 11 PM). The specimen is transported in validated temperature-controlled cold-chain packaging to our ISO 9001:2015 accredited laboratory. Results are reported within 5 working days via secure electronic delivery.

3. Is this test covered by UAE insurance?

Many UAE medical insurers cover this test under hereditary neurometabolic disorder panels when ordered by a physician. We offer direct billing verification via WhatsApp at +971 54 548 8731 before sample collection. Please check with your provider for specific policy coverage.

UAE Regulatory & Data Privacy Adherence

This test is conducted in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled under strict confidentiality protocols. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).

Clinical & Logistical Metadata

Test Name MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes) Mutation Detection
Price (AED) 1,100 AED
Turnaround Time 5 working days (Sunday–Thursday)
Sample Type / Matrix Whole Blood (EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available Daily 8 AM–11 PM
Methodology Used PCR amplification followed by Sanger Sequencing for m.3243A>G variant
ICD-10-CM Code E88.41 (MELAS syndrome)
LOINC Code 58221-6 (MELAS mutation detection)
DHA Facility License & Laboratory Address DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians